• SENSEX 81,463.09
    -721.08 (--0.88%)
  • BANKNIFTY 56,528.90
    -537.15 (--0.94%)
  • Authum Invest
    2,250.00 985.45(%)
  • Indian Energy Ex
    149.45 244.35(%)
  • Vimta Labs
    598.90 598.90(%)
  • Bharti Airtel
    1,952.40 2,045.50(%)
  • Force Motors
    16,488.00 6,128.55(%)
  • Bajaj Finance
    897.65 642.61(%)
  • Anant Raj
    606.00 947.25(%)
  • Jayaswal Neco
    40.05 26.06(%)
  • Sharda Cropchem
    1,090.25 1,090.25(%)
  • Infosys
    1,511.35 1,307.10(%)
  • Olectra Greentec
    1,460.00 973.65(%)
  • Tata Motors
    685.00 542.55(%)
  • Eternal Ltd
    306.25 189.60(%)
  • Trent
    5,033.80 4,491.75(%)
  • Reliance Industr
    1,384.50 1,115.55(%)
  • Waaree Energies
    3,171.00 1,808.65(%)
  • Phoenix Mills
    1,545.00 1,965.00(%)
  • Kajaria Ceramics
    1,151.00 745.00(%)
  • Adani Green
    972.75 758.00(%)
  • Cipla
    1,553.00 1,702.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Sai Life Sciences Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 68121.0
  • ISIN : INE570L01029
838.50 13 (1.57%)
  • As on 26 Jul 2025 (EOD)

  • Today’s Low

    822.50

  • Today’s High

    850.90

  • Open

    825.60

  • Perv Close

    825.50

  • 52W Low

    636.10

  • 52W High

    850.90

Key Indicators

  • P/E(TTM)

    100.84

  • Mar.Cap (₹Cr.)

    17,503.97

  • Div & Yield %

    0.00

  • Book Value(₹)

    103.83

  • Debt-Equity Ratio

    1.57

  • AGM Date

    25-Jul-2025

  • EPS

    8.31

  • P/E Ratio

    100.84

Financials Ratios

  • Debt-Equity Ratio

    1.00

  • Mar.Cap (₹Cr.)

    17,503.97

  • RONW (%)

    8.89

  • ROCE (%)

    10.46

Score Board

  • Equity (₹ in Cr.)

    20.88

  • BV (₹)

    103.80

  • Sales( ₹ in Cr.)

    1,642.05

  • NP (in Cr.)

    173.46

  • NP Var(%)

    82.0

  • Div%

    0.0

  • CPS (₹)

    14.30

  • EPS (₹)

    8.30

  • Traded Value (₹ in Lakhs)

    17,492.49

  • 52 Week High

    850.90

  • 52 Week Low

    636.10

  • Price BSE

    838.0

  • Price NSE

    839.00

  • Market Capital( in Cr.)

    17,492.49

  • P/C Ratio

    58.40

  • P/E Ratio

    100.80

  • Price Vs.BV

    8.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 1,418.68 1,157.40 841.02 751.47 725.36 695.11
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 1,418.68 1,157.40 841.02 751.47 725.36 695.11
Other Income 29.33 27.96 28.15 27.29 17.84 5.63
Stock Adjustments -23.80 4.59 2.83 16.50 5.51 -0.58
Total Income 1,424.21 1,189.95 872.00 795.26 748.71 700.16
EXPENDITURE :            
Raw Materials 408.78 413.12 251.14 232.69 207.72 188.22
Power and Fuel Cost 49.49 43.73 31.86 27.25 27.04 25.36
Employee Cost 430.63 353.76 263.37 203.64 202.50 197.18
Other Manufacturing Expenses 84.73 90.06 78.21 50.32 48.82 46.81
Selling and Administration Expenses 117.15 84.16 84.59 85.45 67.36 54.53
Miscellaneous Expenses 16.06 10.29 9.79 4.44 7.57 7.75
Employee Benefit Expenses 430.63 353.76 263.37 203.64 202.50 197.18
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,106.84 995.11 718.97 603.79 561.01 519.85
Operating Profit 317.37 194.84 153.03 191.46 187.70 180.30
Interest 81.15 74.38 50.98 32.11 21.26 23.78
Gross Profit 236.22 120.46 102.05 159.35 166.44 156.52
Depreciation 107.21 87.77 79.70 71.77 52.36 44.26
Profit Before Tax 129.01 32.69 22.35 87.58 114.08 112.26
Current Tax 7.97 10.73 9.37 3.73 20.48 30.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 25.81 -2.28 -2.70 18.55 13.47 9.37
Reported Net Profit 95.23 24.24 15.68 65.30 80.14 72.90
Extraordinary Items 0.01 -0.38 11.31 0.00 0.00 0.02
Adjusted Net Profit 95.22 24.62 4.37 65.30 80.14 72.88
Adjustment below Net Profit 1.08 2.39 0.00 0.83 0.81 -0.28
P & L Balance brought forward 497.75 478.02 461.76 394.23 314.93 232.37
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 6.90 -0.58 -0.21 1.65 -9.94
P & L Balance carried down 594.05 497.75 478.02 460.57 394.23 314.93
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 383.30 396.30 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 38.33 39.63 0.00 0.00 0.00
Earnings Per Share-Unit Curr 53.92 13.76 8.93 36.65 48.92 44.54
Earnings Per Share(Adj)-Unit Curr - - - - - -
Book Value 572.37 517.79 507.50 486.92 484.05 437.47
Book Value(Adj)-Unit Curr - - - - - -

Shareholding Pattern

  • Promoter Group

    35.15%

  • Public Share Holding

    64.85%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 3,521,560 3,521,560.00 3,521,560 3,521,560
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 3,521,560 1.69 3,521,560 2
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 4,611,290 2.21 4,611,290 2
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 11,199,905 5.37 11,199,905 4
Partnership Firms-Indian (Promoter & Group) 53,961,920 25.88 53,961,920 4
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 69,773,115 33.46 69,773,115 10
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 30,399,524 14.58 30,399,524 98
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 5,219,995 2.50 5,219,995 5
Mutual Funds / UTI 39,050,215 18.73 39,050,215 22
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 861,715 0.41 861,715 2
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 75,531,449 36.22 75,531,449 127
2] Non Institution
Bodies Corporate 632,741 0.30 632,741 113
Clearing Members 27 0.00 27 1
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 7,721,405 3.70 7,667,002 905
Foreign Non Institution Other 34,846,957 16.71 34,846,957 2
Hindu Undivided Families 241,418 0.12 241,418 4,147
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 7,141,290 3.42 7,141,290 9
Individuals holding nominal share capital up to Rs. 1 lakh 6,544,488 3.14 6,539,488 121,059
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 1,669,352 0.80 1,669,352 3
Others 921,500 0.44 921,500 2
Sub Total 59,719,178 28.64 59,659,775 126,241
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 208,545,302 100.00 208,485,899 126,380

Company Background

Sai Life Sciences LtdPharmaceuticals - Indian - Formulations

  • Sai Life Sciences Ltd
  • BSE Code : 68121.0
  • ISIN : INE570L01029

  • Incorporation Year

    1999

  • Registered Office

    Plot #.DS-7 IKP Knowledge Park
    Turkapally (V) Shameerpet Md, Hyderabad,
    Telangana-500078

  • Telephone

    +91 40 6815 6000

  • FAX

  • Chairman

    Ranga Raju Kanumuri

  • Managing Director

    Krishnamraju Kanumuri

  • Company Secretary

    Runa Karan

  • Auditor

    BSR & Associates LLP

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Sai Life Sciences Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Sai Life 837.95 1,448.01 1,418.68 100.84 11.36
Abbott India 33,771.20 6,684.73 6,409.15 50.74 44.95
Astrazeneca Phar 8,832.65 1,756.92 1,716.29 190.77 32.94
P & G Health Ltd 5,831.90 1,166.89 1,151.26 38.54 39.76
Glaxosmi. Pharma 3,154.75 3,866.05 3,723.49 58.15 58.72
Cipla 1,531.10 20,029.57 19,044.85 23.98 21.40
Amrutanjan Healt 679.00 437.58 421.23 38.62 20.84
Fermenta Biotec. 375.35 442.21 430.53 16.34 17.61
Guj. Themis Bio. 363.35 174.19 169.82 81.10 44.82
Bliss GVS Pharma 153.45 703.42 667.20 23.46 9.16
Ambalal Sarabhai 32.88 19.33 4.04 30.44 2.10